Biocon on Friday said it has received the establishment inspection report (EIR) from US health regulator for the post-approval and good manufacturing practice (GMP) inspection of its small molecules manufacturing facility in Bengaluru.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2QyAKCd
via IFTTT
0 comments:
Post a Comment